{
    "answer": "Cosentyx's net sales in the immunology segment for the full year 2024 were approximately USD 7.0 billion, representing an increase of 17.5% on a constant currency basis and 13.5% for Q4 2024. There is an estimated USD 5.0 billion in reported immunology segment revenues for 2023, an increase of 17.4% on a constant currency basis and 6.4% for Q4 2024.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 5,
    "search count": 4,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        935,
        2573,
        4215,
        6055,
        7848
    ]
}